Log In Get Started
Press Releases June 2, 2026 07:30 AM

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

Integra LifeSciences CFO to present at 2026 Jefferies Global Healthcare Conference

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
IART

Integra LifeSciences Holdings Corporation announced that its CFO, Lea Knight, will be presenting at the 2026 Jefferies Global Healthcare Conference on June 3, 2026. The presentation will be webcast live on the company's investor relations site.

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference
IART
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Integra LifeSciences is a global medical technology leader focused on neurosurgery and tissue reconstruction.
  • The CFO's presentation at a major healthcare conference provides insight into the company’s strategy and financials.
  • The webcast offers investors direct access to company updates and potential strategic plans.

PRINCETON, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer Lea Knight will present at the 2026 Jefferies Global Healthcare Conference on June 3, 2026 at 10:30am ET.

A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.

About Integra LifeSciences
Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies are trusted by healthcare professionals to deliver life-saving care. For our latest news and information, visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736
[email protected]   

Media Contact:
Laurene Isip
(609) 208-8121
[email protected]

Integra LifeSciences Holdings Corporation


Risks

  • Market reaction is uncertain as the announcement relates primarily to a forthcoming presentation rather than new product launches or financial results.
  • Potential competitive pressure in the medical technology sector could impact business performance.
  • Economic or regulatory changes in healthcare markets may affect the company’s growth prospects.

More from Press Releases

GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders Jun 7, 2026 Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems Jun 6, 2026 All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration Jun 6, 2026 Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress Jun 6, 2026 InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering Jun 5, 2026